ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Embilica Officinalis

Also known as: Phyllanthus emblica, Amla, Indian gooseberry, Emblica officinalis

Overview

Emblica officinalis, commonly known as Amla or Indian gooseberry, is a fruit-bearing tree native to India and Southeast Asia. The fruit is highly valued in traditional medicine for its rich content of vitamin C, flavonoids, and other polyphenols, which contribute to its potent antioxidant properties. It is primarily used as a herbal supplement to support cardiovascular health, immune function, and reduce inflammation. Research on Emblica officinalis is ongoing, with a moderate level of evidence from clinical trials and systematic reviews supporting its traditional uses, particularly in modulating lipid profiles and blood pressure. It is generally consumed in various forms, including fresh fruit, juice, powder, or extracts.

Benefits

Emblica officinalis offers several evidence-based benefits, particularly for cardiovascular health. A meta-analysis demonstrated significant reductions in total cholesterol by an average of -21.23 mg/dL and LDL-C (bad cholesterol) by -25.12 mg/dL, alongside an increase in HDL-C (good cholesterol) by 4.74 mg/dL after 12 weeks of intervention. These effects are considered clinically significant for individuals with cardiovascular risk factors. Furthermore, a randomized trial showed that Emblica officinalis significantly reduced both systolic and diastolic blood pressure when used as an adjunct to standard therapy. While the primary benefits are cardiovascular, some studies also suggest a potential reduction in inflammatory biomarkers like C-reactive protein. The benefits typically manifest within weeks to months of consistent use, though long-term effects require further confirmation. The quality of evidence is moderate, with promising results from clinical trials and systematic reviews.

How it works

Emblica officinalis exerts its beneficial effects primarily through its potent antioxidant and anti-inflammatory properties. Its rich content of vitamin C, flavonoids, and polyphenols helps neutralize free radicals, reducing oxidative stress throughout the body. This antioxidant action is crucial for protecting cardiovascular cells and tissues. It is also believed to influence lipid metabolism, contributing to its cholesterol-lowering effects, although the exact molecular targets are not fully elucidated. The anti-inflammatory pathways it modulates likely contribute to its observed effects on blood pressure and overall cardiovascular health. While its interaction with various body systems is evident, the bioavailability of its active compounds is not yet well-studied.

Side effects

Emblica officinalis is generally considered safe for appropriate use. The most commonly reported side effect is gastrointestinal upset, which may occur in some individuals. Uncommon and rare side effects are not well-documented. Caution is advised regarding potential drug interactions; Emblica officinalis may interact with blood thinners due to its antioxidant properties and could potentially affect blood sugar levels, necessitating caution in individuals taking diabetes medications. It is contraindicated during pregnancy and breastfeeding due to insufficient safety data. Individuals with diabetes or those on anticoagulant therapy should consult a healthcare professional before using Emblica officinalis to avoid adverse effects or interactions.

Dosage

While a minimum effective dose for Emblica officinalis is not definitively established, typical daily dosages range from 500 mg to 1,000 mg. Clinical studies frequently utilize doses between 500 mg and 2,000 mg per day to achieve therapeutic effects, particularly for cardiovascular benefits. The maximum safe dose has not been formally established, but higher doses may increase the likelihood of gastrointestinal side effects. It is generally recommended to take Emblica officinalis with meals to minimize potential gastrointestinal upset and potentially enhance absorption. It is commonly available in capsule or tablet forms. No specific cofactors are known to be required for its efficacy.

FAQs

Is Emblica officinalis safe to use?

Yes, it is generally considered safe, but some individuals may experience gastrointestinal upset. Monitor for any adverse reactions.

When is the best time to take Emblica officinalis?

It is best taken with meals to help minimize potential gastrointestinal discomfort and may improve absorption.

How long does it take to see benefits from Emblica officinalis?

Improvements in cardiovascular risk factors, such as cholesterol and blood pressure, may be observed within weeks to months of consistent use.

Can Emblica officinalis replace my prescribed medications?

No, Emblica officinalis is not a substitute for medical treatment. Always consult a healthcare provider before starting any new supplement, especially if you are on medication.

Research Sources

  • https://pdfs.semanticscholar.org/5d5e/b908ffb1c59610071088d8da7badfc3b951b.pdf – This systematic review and meta-analysis of four randomized controlled trials involving 227 participants found that Emblica officinalis significantly reduced total cholesterol and LDL-C, while increasing HDL-C over 12 weeks. The study highlights its potential for cardiovascular health, though it notes limitations due to the small number of included studies.
  • https://pubmed.ncbi.nlm.nih.gov/37296402/ – This systematic review and meta-analysis investigated the effects of Emblica officinalis on cardiovascular risk factors in adults. It concluded that Emblica officinalis has beneficial effects, but noted heterogeneity in study designs. The review supports the ingredient's potential in cardiovascular health management.
  • https://onlinelibrary.wiley.com/doi/10.1155/2020/8592869 – This randomized, triple-blind, placebo-controlled trial with 92 patients with uncontrolled hypertension demonstrated that Emblica officinalis significantly reduced both systolic and diastolic blood pressure over an 8-week period. The study suggests its utility as an adjunct therapy for hypertension, despite its relatively small sample size.